FR2673952B1 - - Google Patents

Info

Publication number
FR2673952B1
FR2673952B1 FR9103108A FR9103108A FR2673952B1 FR 2673952 B1 FR2673952 B1 FR 2673952B1 FR 9103108 A FR9103108 A FR 9103108A FR 9103108 A FR9103108 A FR 9103108A FR 2673952 B1 FR2673952 B1 FR 2673952B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9103108A
Other languages
French (fr)
Other versions
FR2673952A1 (en
Inventor
Marilyne Sasportes
Jurg Tschopp
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to FR9103108A priority Critical patent/FR2673952A1/en
Priority to PCT/FR1992/000240 priority patent/WO1992016644A1/en
Priority to CA 2106193 priority patent/CA2106193A1/en
Priority to EP19920909090 priority patent/EP0575539A1/en
Priority to JP4508582A priority patent/JPH06506112A/en
Publication of FR2673952A1 publication Critical patent/FR2673952A1/en
Application granted granted Critical
Publication of FR2673952B1 publication Critical patent/FR2673952B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6467—Granzymes, e.g. granzyme A (3.4.21.78); granzyme B (3.4.21.79)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR9103108A 1991-03-14 1991-03-14 MEANS FOR THE IN VITRO DIAGNOSIS OF COMPONENTS OF CYTOPLASMIC GRANULES AND BIOLOGICAL APPLICATIONS. Granted FR2673952A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR9103108A FR2673952A1 (en) 1991-03-14 1991-03-14 MEANS FOR THE IN VITRO DIAGNOSIS OF COMPONENTS OF CYTOPLASMIC GRANULES AND BIOLOGICAL APPLICATIONS.
PCT/FR1992/000240 WO1992016644A1 (en) 1991-03-14 1992-03-16 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications
CA 2106193 CA2106193A1 (en) 1991-03-14 1992-03-16 Means for in vitro diagnosis of constituents of cytoplasmic granules and biological applications
EP19920909090 EP0575539A1 (en) 1991-03-14 1992-03-16 Means for in-vitro diagnosis of constituents of cytoplasmic granules and biological applications
JP4508582A JPH06506112A (en) 1991-03-14 1992-03-16 Means for in vitro diagnosis of cytoplasmic granule components and their biological applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9103108A FR2673952A1 (en) 1991-03-14 1991-03-14 MEANS FOR THE IN VITRO DIAGNOSIS OF COMPONENTS OF CYTOPLASMIC GRANULES AND BIOLOGICAL APPLICATIONS.

Publications (2)

Publication Number Publication Date
FR2673952A1 FR2673952A1 (en) 1992-09-18
FR2673952B1 true FR2673952B1 (en) 1995-05-12

Family

ID=9410734

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9103108A Granted FR2673952A1 (en) 1991-03-14 1991-03-14 MEANS FOR THE IN VITRO DIAGNOSIS OF COMPONENTS OF CYTOPLASMIC GRANULES AND BIOLOGICAL APPLICATIONS.

Country Status (5)

Country Link
EP (1) EP0575539A1 (en)
JP (1) JPH06506112A (en)
CA (1) CA2106193A1 (en)
FR (1) FR2673952A1 (en)
WO (1) WO1992016644A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2887060B2 (en) * 1993-06-30 1999-04-26 日清製粉株式会社 Gricentin production method
US5858758A (en) * 1997-05-07 1999-01-12 Incyte Pharmaceuticals, Inc. Human serine protease precursor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783410A (en) * 1985-06-28 1988-11-08 Massachusetts Institute Of Technology Cytotoxic t lymphocyte serine esterase and method for stimulation and inhibition
EP0245051B1 (en) * 1986-05-06 1992-08-12 The Board Of Trustees Of The Leland Stanford Junior University Killer cell cytotoxic composition

Also Published As

Publication number Publication date
JPH06506112A (en) 1994-07-14
FR2673952A1 (en) 1992-09-18
WO1992016644A1 (en) 1992-10-01
EP0575539A1 (en) 1993-12-29
CA2106193A1 (en) 1992-09-15

Similar Documents

Publication Publication Date Title
FR2681164B1 (en)
FR2671931B1 (en)
FR2676147B1 (en)
FR2673017B1 (en)
FR2673252B1 (en)
CH681761GA3 (en)
EP0525335A3 (en)
EP0512438A3 (en)
FR2678330B1 (en)
DK0520894T3 (en)
FR2675070B1 (en)
FR2681868B1 (en)
FR2672278B1 (en)
FR2680352B1 (en)
FR2676255B1 (en)
FR2675678B1 (en)
FR2674650B1 (en)
FR2679328B1 (en)
FR2681281B1 (en)
ECSM91565U (en)
ECSM91549U (en)
ECSM91535U (en)
ECSDI910051S (en)
EP0498366A3 (en)
EP0522702A3 (en)

Legal Events

Date Code Title Description
ER Errata listed in the french official journal (bopi)

Free format text: 38/92

ST Notification of lapse